Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G KETTLE

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|December 4, 2004
Optimization of parathyroid imaging by simultaneous dual energy planar and single photon emission tomographyVijay S Dontu, Andrew G Kettle, Michael J O'Doherty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1992
Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studiesM J O'Doherty, A G Kettle, P Wells, et al.
RSC Medicinal Chemistry|May 28, 2021
Drugging the undruggable: a computational chemist's view of KRAS<sup>G12C</sup>Michael S Bodnarchuk, Doyle J Cassar, Jason G Kettle, et al.
Nuclear Medicine Communications|June 13, 1998
Can chest X-rays and ventilation/perfusion scans be interpreted reliably from personal computer screens?E R Denton, S F Barrington, A G Kettle, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to boneP J Blower, A G Kettle, M J O'Doherty, et al.
European Journal of Nuclear Medicine|August 3, 2014
(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to boneP J Blower, A G Kettle, M J O'Doherty, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Nuclear Medicine Communications|March 1, 1993
Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisM J O'Doherty, A G Kettle, C N Eustance, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptorJason G Kettle, Alan W Faull, Andy J Barker, et al.
Nuclear Medicine Communications|July 1, 1992
123I-methylene blue: an unsatisfactory parathyroid imaging agentP J Blower, A G Kettle, M J O'Doherty, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|December 4, 2004
Optimization of parathyroid imaging by simultaneous dual energy planar and single photon emission tomographyVijay S Dontu, Andrew G Kettle, Michael J O'Doherty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1992
Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studiesM J O'Doherty, A G Kettle, P Wells, et al.
RSC Medicinal Chemistry|May 28, 2021
Drugging the undruggable: a computational chemist's view of KRAS<sup>G12C</sup>Michael S Bodnarchuk, Doyle J Cassar, Jason G Kettle, et al.
Nuclear Medicine Communications|June 13, 1998
Can chest X-rays and ventilation/perfusion scans be interpreted reliably from personal computer screens?E R Denton, S F Barrington, A G Kettle, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to boneP J Blower, A G Kettle, M J O'Doherty, et al.
European Journal of Nuclear Medicine|August 3, 2014
(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to boneP J Blower, A G Kettle, M J O'Doherty, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Nuclear Medicine Communications|March 1, 1993
Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisM J O'Doherty, A G Kettle, C N Eustance, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptorJason G Kettle, Alan W Faull, Andy J Barker, et al.
Nuclear Medicine Communications|July 1, 1992
123I-methylene blue: an unsatisfactory parathyroid imaging agentP J Blower, A G Kettle, M J O'Doherty, et al.
Pageof 8